[ad_1] [Seoul-NewYes] Kolong Tissue Jean's young reporter will enter the third phase of clinical trials to seek US Food and Drug Administration (FDA) approval in 2021 for the first gene therapy product …
Read More »Lee Woo-suk, CEO of Kolon Tissuechin, said: "Invoices,
